Alzheimer's study reveals key difference between men and women
Researchers discovered that women with Alzheimer's exhibit a noticeable loss of unsaturated fats, including omega fatty acids, in their blood compared to healthy women.
The study, conducted by King's College London and Queen Mary University London, found significant differences in fat molecules in women with the disease, a pattern not observed in men.
This sex-specific difference in lipid biology may offer insights into why more women are diagnosed with Alzheimer's than men.
Scientists recommend that women ensure adequate omega fatty acid intake through diet or supplements, though further clinical trials are needed to confirm if altering lipid composition can influence the disease's progression.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BreakingNews.ie
an hour ago
- BreakingNews.ie
Alcohol harm costing workplaces €8.5 billion in lost productivity
Alcohol abuse is costing Irish workplaces €8.5 billion a year in lost productivity, according to Alcohol Action Ireland (AAI). Alcohol Action Ireland (AAI), the national independent advocate to reduce alcohol harm, has published its latest report on the impact that alcohol has on the Irish economy and urges the government to implement policies that will reduce this heavy burden. Alcohol's impact on public health and the health service, on crime and the criminal justice system, and on road traffic collisions is well documented. Advertisement However, another area which is directly and indirectly affected by alcohol, but which has received far too little attention, is the workplace. AAI's latest report, titled Alcohol's Cost to the Workplace , uses national and international evidence to shine a light on the impact of alcohol in the workplace in Ireland, the scale of its impact on workers, on employers, and on the economy. The report found employers and businesses can sometimes be a major contributor themselves to alcohol use amongst workforces. However, there is a role for employers and the trade union movement to reduce this by ensuring positive work conditions including fair treatment, recognition, meaningful work, skill variety, autonomy, acquisition and use of skills, fair rewards, promotion opportunities, friendship formation, and social support from co-workers and supervisors. Advertisement Heavy drinking increases the risk of absenteeism, with high-risk drinkers 22 times more likely to be absent from work due to their alcohol use compared with lower-risk drinkers. Presenteeism – which is defined as being physically present at work but, due to a physical or emotional issue, being distracted to the point of reduced productivity – is more important for lost productivity than is absenteeism, with presenteeism accounting for 77 per cent of total lost productivity in the workplace, while absenteeism is responsible for 23 per cent. It is estimated that heavy drinking increases the risk of unemployment by as much as about five-fold compared with light drinking. Speaking about the report, AAI chief executive Dr Sheila Gilheany said: 'Alcohol is by far the most used psychoactive substance in the workforce, with people having harmful consumption patterns that increase their risk of social, legal, medical, occupational, domestic and economic problems. Advertisement More than half of Irish drinkers are classified as hazardous drinkers. Within that cohort of hazardous drinkers, there are 578,000 people with an alcohol use disorder (AUD), of which 90,000 are at a severe level. 'Alcohol poses a significant risk to workers, to businesses, to productivity and to the economy. "Workers under the influence of alcohol can be a danger to themselves and to others, especially in jobs which involve a high risk of injury. "Working under the influence of alcohol, or with a hangover, can increase the risk of accidents, injuries and absenteeism, along with tardiness at work and/or leaving work early, resulting in loss of productivity. It can also lead to the development of inappropriate behaviour at work, poor relations with colleagues, and low company morale. Advertisement Ireland Man (29) claims self-defence after beating 59-year... Read More 'The impact of alcohol on the workplace is multifaceted. It affects the individual in terms of mortality and morbidity, productivity, presenteeism, and absenteeism. It affects colleagues in terms of workload, and it affects employers in terms of businesses losses and competitiveness. "However, the workplace also represents a useful access point for health promotion, including for addressing alcohol-related harm. Implementing workplace interventions to reduce hazardous drinking levels can have a positive economic impact by reducing absenteeism, presenteeism, accidents and injuries.' Dr Gilheany said that alcohol harm is estimated to cost the Irish exchequer about 2.5 per cent of GDP every year – that is €14 billion for 2024 – in health, justice and lost productivity. Of this, the lion's share – 61 per cent or about €8.5 billion – is due to lost productivity. She said given alcohol's huge drain on the Irish economy, much more could be done by government to address these issues.
The Independent
an hour ago
- The Independent
A hearing aid before the age of 70 can dramatically reduce risk of dementia, new research finds
People who use a hearing aid before the age of 70 can dramatically reduce their risk of dementia, new research shows. Dementia, which is the loss of cognitive functioning, affects more than six million Americans and leads to more than 100,000 deaths each year, according to the National Institutes of Health. As the U.S. population ages, dementia cases are expected to double by 2060, NIH says. Age-related hearing loss is a risk factor for developing dementia, and a research letter published in JAMA Neurology on Monday found that using hearing aids could reduce this risk. After studying nearly 3,000 participants over up to two decades researchers found those with hearing loss who used hearing aids had a 61 percent lower risk for dementia among those younger than 70 years at the time of their hearing loss diagnosis. 'This finding highlights the importance of early intervention for HL [hearing loss] for possible prevention of dementia,' the authors of the study wrote. But the study noted only 17 percent of people with moderate to severe hearing loss use hearing aids. UCLA Health gave three possible theories for the link between hearing loss and dementia including that hearing loss causes the brain to deteriorate faster. Additionally, your brain works harder to understand conversation when you can't hear well. Straining your brain regularly like this can impact your cognitive function. Hearing loss can also limit your social engagement as conversing in noisy environments is less enjoyable. Your brain may struggle to be intellectually stimulated without socialization. Age-related hearing loss affects one in three people older than 60, according to the American Academy of Audiology. One in two people older than the age of 85 has hearing loss. Common signs of hearing loss include asking people to repeat things, difficulty hearing and understanding speech in noisy settings, and turning the TV or radio up louder than normal. The American Academy of Audiology warns untreated hearing loss can be connected to cognitive decline as well as depression, anxiety, paranoia and poor social relationships.
Daily Mail
2 hours ago
- Daily Mail
Mysterious blue brain found in autopsy linked to RFK Jr's 'miracle cure'
A substance touted by health secretary Robert F Kennedy Jr as a 'miracle cure-all' has been found to dramatically change the color of internal organs, according to a new study. Researchers at University Hospital Frankfurt in Germany examined the bodies of 11 people and discovered that methylene blue, a synthetic dye long used to treat conditions like malaria and methemoglobinemia. Methylene blue may also help combat other health problems, including urinary tract infections and depression, experts have said. During the autopsies, researchers discovered that the brains, hearts, lungs, and pancreases had turned a striking shade of blue. Even small doses, as little as 25 milligrams, roughly a quarter of a standard aspirin tablet, were enough to alter brain pigment, the team concluded. Some individuals had received 50 to 200 milligrams intravenously for medical conditions, with multiple doses given within 10 hours of death, and all showed discoloration of the brain and heart. The researchers emphasized that while the color changes darkened upon exposure to air during autopsies, the effect was not linked to the causes of death. Instead, it highlights how methylene blue persists in the body and can dramatically affect organ appearance, raising questions for forensic and medical examinations. The individuals who received methylene blue in the hospital were generally being treated for severe medical conditions, often involving life-threatening shock or critical illnesses. Most were in intensive care units (ICUs) for issues like septic shock from infections, heart failure, complications following surgeries, or severe COVID-19 infections. Hospital staff administered the dye intravenously as a last-resort treatment to improve blood flow and oxygen delivery when standard treatments failed. The startling discovery, published in the journal Forensic Science, Medicine and Pathology, was made while researchers were conducting an autopsy on a 72-year-old man and found his brain was blue. To understand why, they searched their institute's database of 15,820 autopsy records from 2000 to 2023, looking for similar cases of doctors finding 'blue-green,' 'greenish,' or 'turquoise' organs during autopsies. They found 11 cases, including the 72-year-old, where various organs throughout the body had this unusual color. In each case, they found that six of these individuals with blue organs had ingested or been given a dosage of methylene blue shortly before their deaths. The other five had received or ingested a medical dye called toluidine blue, a sedative called Rohypnol that contains the blue dye indigocarmine, or a cleaning agent with the blue dye Brilliant Blue FCF. Study authors in Germany found 6 people who received dosages of methylene blue while in the hospital had blue brains and hearts after death The patients had taken the medical dye as a last resort treatment for various illnesses, including COVID-19 Although RFK Jr has not publicly confirmed that he uses methylene blue, a February 2025 video showed the health secretary putting droplets of a cobalt-blue liquid into what looked like water. Recent studies have explored its use in fighting early-stage COVID-19 by potentially reducing viral damage and improving oxygen delivery. It's also been investigated for its ability to boost brain health, treat shock, and potentially as an anti-aging serum. Some research has even suggested it can kill cancer cells under specific conditions. In fact, actor Mel Gibson claimed three of his friends recovered from stage four cancer after taking a supplement regimen that included methylene blue. In fact, actor Mel Gibson claimed three of his friends recovered from stage four cancer after taking a supplement regimen that included methylene blue. The Daily Mail has requested a comment from RFK Jr and the Department of Health and Human Services about the findings and is awaiting a response. While medical professionals only use the dye in extreme cases, methylene blue has taken over TikTok and Instagram with claims it can sharpen focus and boost mood. Methylene blue is FDA approved to treat the rare blood disorder methemoglobinemia, though it has also been used off label for anti-aging and cancer Influencers have dubbed it 'brain fuel' and a 'limitless pill,' with some studies claiming it can also alleviate mental health issues. However, neuroscientist Anne-Sophie Fluri told the Daily Mail in June that many of the supposed benefits being promoted online are based on preliminary research using rodents or petri dishes, not conclusive human clinical trials. The US Food and Drug Administration (FDA) has issued a public safety warning about methylene blue's potential to cause serotonin syndrome when combined with common antidepressants like Prozac, Zoloft, or Cymbalta. Serotonin syndrome is a dangerous condition caused by too much serotonin in the body, leading to symptoms like confusion, high fever, seizures, and, in rare cases, death. Methylene blue can trigger this syndrome when taken with antidepressants because it blocks an enzyme that normally breaks down serotonin, causing a harmful buildup.
